Praram 9 Hospital Future Growth

Future criteria checks 2/6

Praram 9 Hospital is forecast to grow earnings and revenue by 12% and 8.3% per annum respectively. EPS is expected to grow by 12.3% per annum. Return on equity is forecast to be 14.4% in 3 years.

Key information

12.0%

Earnings growth rate

12.3%

EPS growth rate

Healthcare earnings growth	10.0%
Revenue growth rate	8.3%
Future return on equity	14.4%
Analyst coverage	Good
Last updated	06 Dec 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

SET:PR9 - Analysts future estimates and past financials data (THB Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	5,517	898	893	1,246	7
12/31/2025	5,153	814	694	1,148	8
12/31/2024	4,693	707	713	1,043	8
9/30/2024	4,605	694	781	1,016	N/A
6/30/2024	4,447	626	668	907	N/A
3/31/2024	4,365	608	553	880	N/A
12/31/2023	4,253	558	497	804	N/A
9/30/2023	4,178	509	535	828	N/A
6/30/2023	4,175	516	520	782	N/A
3/31/2023	4,139	519	674	845	N/A
12/31/2022	4,150	568	730	893	N/A
9/30/2022	3,980	545	675	897	N/A
6/30/2022	3,665	481	637	885	N/A
3/31/2022	3,327	368	438	710	N/A
12/31/2021	3,026	249	336	588	N/A
9/30/2021	2,826	214	261	496	N/A
6/30/2021	2,767	204	205	498	N/A
3/31/2021	2,646	203	-54	434	N/A
12/31/2020	2,633	202	-316	424	N/A
9/30/2020	2,637	195	-478	384	N/A
6/30/2020	2,686	211	-608	359	N/A
3/31/2020	2,841	236	-523	444	N/A
12/31/2019	2,876	284	-349	490	N/A
9/30/2019	2,842	178	-616	520	N/A
6/30/2019	2,809	176	-510	511	N/A
3/31/2019	2,774	191	-366	514	N/A
12/31/2018	2,727	157	-337	480	N/A
9/30/2018	2,689	274	6	428	N/A
6/30/2018	2,620	268	N/A	451	N/A
3/31/2018	2,543	266	N/A	456	N/A
12/31/2017	2,455	262	N/A	440	N/A
12/31/2016	2,259	267	N/A	N/A	N/A
12/31/2015	1,982	194	N/A	N/A	N/A
12/31/2014	1,794	162	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PR9's forecast earnings growth (12% per year) is above the savings rate (2%).

Earnings vs Market: PR9's earnings (12% per year) are forecast to grow slower than the TH market (16.8% per year).

High Growth Earnings: PR9's earnings are forecast to grow, but not significantly.

Revenue vs Market: PR9's revenue (8.3% per year) is forecast to grow faster than the TH market (6.6% per year).

High Growth Revenue: PR9's revenue (8.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PR9's Return on Equity is forecast to be low in 3 years time (14.4%).

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 07:46
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Praram 9 Hospital Public Company Limited is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Charti Phrawphraikul	BofA Global Research
Narumon Ekasamut	Bualuang Securities PCL
Panjapon Taensricharoen	Bualuang Securities PCL

Praram 9 Hospital Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target increased by 8.0% to ฿26.64

Price target increased by 7.7% to ฿25.56

Price target decreased by 7.1% to ฿19.67

Price target increased to ฿18.17

Consensus EPS estimates increase by 35%

Price target increased to ฿15.40

Recent updates

Upcoming dividend of ฿0.15 per share

Third quarter 2024 earnings: EPS exceeds analyst expectations

Price target increased by 8.0% to ฿26.64

Price target increased by 7.7% to ฿25.56

Second quarter 2024 earnings: EPS misses analyst expectations

First quarter 2024 earnings released: EPS: ฿0.20 (vs ฿0.14 in 1Q 2023)

Upcoming dividend of ฿0.30 per share

Praram 9 Hospital Public Company Limited Announces Chief Finance Officer Changes

Praram 9 Hospital Public Company Limited Announces Chief Finance Officer Changes

Dividend increased to ฿0.30

Praram 9 Hospital Public Company Limited Proposes Cash Dividend for 2023 , Payable on May 20, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Praram 9 Hospital Public Company Limited, Annual General Meeting, Apr 23, 2024

Investor sentiment improves as stock rises 17%

Price target decreased by 7.1% to ฿19.67

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Now 21% undervalued after recent price drop

Now 20% undervalued

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

First quarter 2023 earnings released: EPS: ฿0.14 (vs ฿0.20 in 1Q 2022)

Upcoming dividend of ฿0.29 per share at 1.5% yield

Now 21% undervalued after recent price drop

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 22% undervalued after recent price drop

Less than half of directors are independent

Price target increased to ฿18.17

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates increase by 35%

Investor sentiment improved over the past week

Price target increased to ฿15.40

First quarter 2022 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 22%

Upcoming dividend of ฿0.14 per share

Less than half of directors are independent

Praram 9 Hospital Public Company Limited Announces Termination of Paphada Kladkhemphet as Chief Accountant

Praram 9 Hospital Public Company Limited Proposes Dividend for the Year 2021, Payable on May 19, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued after recent price drop

Third quarter 2021 earnings released

Second quarter 2021 earnings released: EPS ฿0.015 (vs ฿0.014 in 2Q 2020)

Consensus EPS estimates fall to ฿0.17

Consensus EPS estimates fall to ฿0.27

First quarter 2021 earnings released: EPS ฿0.049 (vs ฿0.047 in 1Q 2020)

Upcoming dividend of ฿0.11 per share

Analysts lower EPS estimates to ฿0.33

Full year 2020 earnings released: EPS ฿0.26 (vs ฿0.36 in FY 2019)

Revenue and earnings beat expectations

Praram 9 Hospital Public Company Limited, Annual General Meeting, Apr 23, 2021

New 90-day high: ฿10.10

Analysts update estimates

Price target raised to ฿9.20

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ฿0.092

New 90-day high: ฿8.65

Market bids up stock over the past week

New 90-day high: ฿7.75

New 90-day high: ฿7.00

First half earnings released

New 90-day low - ฿6.50